David P Schenkein MD

Hematologic Oncology

Physician

800 Washington StTufts Medical Center Box 836Boston, MA 02111
Phone+1 617-636-7652

Dr. Schenkein is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Schenkein's full profile Already have an account?

Education & Training

Tufts Medical CenterFellowship, Hematology and Medical Oncology, 1986 - 1989
Tufts Medical CenterResidency, Internal Medicine, 1983 - 1986
SUNY Upstate Medical UniversityClass of 1983

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

MA State Medical License 1985 - 2028
CA State Medical License 2006 - 2022
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology

Clinical Trials

SWOG-9704 Chemoradiotherapy and Peripheral Stem Cell Transplantation Compared With Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma
COMPLETED
PHASE3

Publications & Presentations

PubMed

12 citations
Enasidenib treatment in two individuals with D-2-hydroxyglutaric aciduria carrying a germline IDH2 mutation.
Birgit Geoerger, Manuel Schiff, Virginie Penard-Lacronique, Niklas Darin, Selim-Maria Saad
Nature Medicine. 2023-06-01
2 citations
US immigration order strikes against biotech
Jeremy M Levin, Steven H Holtzman, John M. Maraganore, Paul Hastings, Ron Cohen
Nature Biotechnology. 2017-03-07
103 citations
IDH2 mutation-induced histone and DNA hypermethylation is progressively reversed by small-molecule inhibition.
Andrew Kernytsky, Fang Wang, Erica Hansen, Stefanie Schalm, Kimberly Straley
Blood. 2015-01-08

Press Mentions

Luba Greenwood Takes the Helm at Kojin Therapeutics, Steering an All-Female C-suite; Alexion R&D Chief Packs up for Change of Scenery at VC FirmOctober 15th, 2021
Bluebird Bio to Separate Oncology Business into Independent CompanyJanuary 11th, 2021
RESILIENCE Launches to Change the Future of Medicine Through Manufacturing InnovationNovember 23rd, 2020

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Similar Physicians & HCPs

Stephen Louie, MD
OncBoston, MA
Vijay Kasturi, MD
OncBoston, MA
Raymond Comenzo, MD
OncBoston, MA
Virginia Zaleskas, MD
OncBoston, MA
Rachel Buchsbaum, MD
OncBoston, MA
Don Dizon, MD
OncBoston, MA
Elaine Choi, MD
OncBoston, MA
Lori Pai, MD
OncBoston, MA
Frank Haluska, MD
OncBoston, MA
Paul Mathew, MD
OncBoston, MA

Doximity / States / Massachusetts / Boston / David Schenkein, MD

Dr. David Schenkein, Dr. David Schenkein, MD, Dr. D Schenkein, Dr. David P Schenkein